Galenica AG

Galenica AG

GALNF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.54B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Galenica AGGalenica AG28.62.74%25%0.60.8
$115.67

Current Fair Value

16.3% upside

Undervalued by 16.3% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.54 Billion
Enterprise Value$5.63 Billion
Annual dividend$1.59
Dividend yield2.74%
Earnings per Share$3.63
Beta0.29
Outstanding Shares49,889,473

Return

Return on Equity24.89%ROE
Return on Assets10.57%
Return on Invested Capital18.96%

Valuation & Multiples

P/E Ratio28.59P/E Ratio
PEG-115.13PEG
Price to Sales0.6Price to Sales
Price to Book Ratio3.55Price to Book Ratio
Enterprise Value to Revenue0.68
Enterprise Value to EBIT13.01
Enterprise Value to Net Income16
Total Debt to Enterprise0.2
Debt to Equity0.8Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 6, 2026
EPS
$2.26
Est. $2.39
Revenue
$2.64 B
Est. $2.63 B

Next Earnings Call

Expected Date
March 9, 2027
EPS Estimate
$2.37
Consensus analyst estimate
Revenue Estimate
$2.69 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Galenica AG

6,558 employees
CEO: Marc Werner

Galenica AG operates as a prominent healthcare services provider, delivering solutions across Switzerland and internationally. Its operations are structured into two core divisions: Products & Care, and Logistics & Information Technology...